The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

NCT02943252 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Apatinib
DRUG: S1

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences